SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001367644-23-000207
Filing Date
2023-12-11
Accepted
2023-12-11 07:17:14
Documents
133
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A ebs-20221231.htm   iXBRL 10-K/A 3286138
2 EX-23 a23-eyxemergentconsent10xk.htm EX-23 7288
3 EX-31.1 a311-millercert12312210xka.htm EX-31.1 8508
4 EX-31.2 a312-lindahlcert12312210xka.htm EX-31.2 8572
5 EX-32.1 a321-millercert12312210xka.htm EX-32.1 3557
6 EX-32.2 a322-lindahlcert12312210xka.htm EX-32.2 3407
12 ebs-20221231_g1.jpg GRAPHIC 75656
  Complete submission text file 0001367644-23-000207.txt   17956596

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ebs-20221231.xsd EX-101.SCH 82459
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ebs-20221231_cal.xml EX-101.CAL 131635
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ebs-20221231_def.xml EX-101.DEF 588927
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ebs-20221231_lab.xml EX-101.LAB 1098398
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ebs-20221231_pre.xml EX-101.PRE 889985
127 EXTRACTED XBRL INSTANCE DOCUMENT ebs-20221231_htm.xml XML 3677741
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33137 | Film No.: 231476904
SIC: 2834 Pharmaceutical Preparations